Concepedia

Author

Philippe Jacqmin

Janssen (Belgium)

Also Known As

F. Gueyffier, Jacqmin, Philippe, P JACQMIN, P Jacqmin, P. JACQMIN, P. Jacqmin, Philippe Jacqmin, Yi-jin Gao

87

Publications

2.1K

Citations

22

H-Index

46

Concepts

All Affiliations

Janssen (Belgium)Bambino Gesù Children's HospitalExpro (United Kingdom)University College LondonCincinnati Children's Hospital Medical Center
PJ

About

Philippe Jacqmin is an author at Janssen (Belgium) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

434

2

Health Sciences

2

2

21

3

Engineering

1

1

11

4

Public Health

1

1

86

5

Biochemistry

1

1

11

Philippe Jacqmin

×

30

Publications

1.8K

Citations

20

H-Index

YearCitations

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

Franco Locatelli, Michael B. Jordan, Carl E. Allen,

New England Journal of Medicine

2020

480

Modelling Response Time Profiles in the Absence of Drug Concentrations: Definition and Performance Evaluation of the K–PD Model

Philippe Jacqmin, Eric Snoeck, E.A. van Schaick,

Journal of Pharmacokinetics and Pharmacodynamics

2006

160

Repeated-Dose Pharmacokinetics of an Oral Solution of Itraconazole in Infants and Children

Louis de Repentigny, Johanne Ratelle, Jean‐Marie Leclerc,

Antimicrobial Agents and Chemotherapy

1998

143

Efficacy and safety of emapalumab in macrophage activation syndrome

Fabrizio De Benedetti, Alexei A. Grom, Paul Brogan,

Annals of the Rheumatic Diseases

2023

122

A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure

Eric Snoeck, Pascal Chanu, Marc Lavielle,

Clinical Pharmacology & Therapeutics

2010

110

The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects

Phylinda L. S. Chan, Philippe Jacqmin, Marc Lavielle,

Journal of Pharmacokinetics and Pharmacodynamics

2010

86

Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS

Emmanuel Monnet, G Lapeyre, Eveline P. van Poelgeest,

Clinical Pharmacology & Therapeutics

2016

75

Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study

Emmanuel Monnet, Ernest Choy, Iain B. McInnes,

Annals of the Rheumatic Diseases

2019

69

Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR‐SOB Scores From ADNI

I Delor, J‐E Charoin, Ronald Gieschke,

CPT Pharmacometrics & Systems Pharmacology

2013

59

Retrospective Population Pharmacokinetic Analysis of Levetiracetam in Children and??Adolescents with Epilepsy

Nathalie Toublanc, Maria Laura Sargentini‐Maier, Brigitte Lacroix,

Clinical Pharmacokinetics

2008

58

Page 1